A legal advisor to the European Court of Justice has dealt a further setback to European Commission President Ursula von der Leyen regarding the confidentiality surrounding the EU’s vaccine procurement negotiations during the COVID-19 pandemic. The advisor stated the Commission should have proactively disclosed communications with pharmaceutical companies like Pfizer. This opinion relates to a case brought by a journalist seeking access to text messages exchanged between von der Leyen and Pfizer CEO Albert Bourla. The advisor’s assessment suggests the public has a right to know details of these negotiations, which occurred during a critical period of public health crisis. While not a final ruling, the Court of Justice often follows the advice of its advisors. The case, dubbed “Pfizergate,” centers on allegations of a lack of transparency in the vaccine purchasing process. A final decision from the court is expected in the coming months.